Covered recipient · General Payments record
JAMESON T LOYAL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$14,673.67
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,300.00 | 1 |
| Food and Beverage | $1,158.09 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,886.80 | 22 |
| Galderma Laboratories, L.P. | $353.15 | 4 |
| MERZ NORTH AMERICA, INC. | $163.59 | 3 |
| REVANCE THERAPEUTICS, INC. | $54.55 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.01 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906732 | CMS |
| ABBVIE INC. | $83.72 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906734 | CMS |
| ABBVIE INC. | $20.53 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906736 | CMS |
| ABBVIE INC. | $4.10 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906738 | CMS |
| ABBVIE INC. | $29.46 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906740 | CMS |
| ABBVIE INC. | $31.08 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906742 | CMS |
| ABBVIE INC. | $28.42 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906744 | CMS |
| ABBVIE INC. | $24.59 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906746 | CMS |
| ABBVIE INC. | $1,300.00 | 07/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104906748 | CMS |
| ABBVIE INC. | $2.22 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906750 | CMS |
| ABBVIE INC. | $27.31 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906752 | CMS |
| ABBVIE INC. | $13.28 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906754 | CMS |
| ABBVIE INC. | $126.06 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906756 | CMS |
| ABBVIE INC. | $25.98 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906758 | CMS |
| ABBVIE INC. | $8.73 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906760 | CMS |
| ABBVIE INC. | $20.60 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906762 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906764 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906766 | CMS |
| ABBVIE INC. | $19.85 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906768 | CMS |
| ABBVIE INC. | $21.74 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906770 | CMS |
| ABBVIE INC. | $22.66 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906772 | CMS |
| ABBVIE INC. | $25.88 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104906774 | CMS |
| Galderma Laboratories, L.P. | $207.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145313983 | CMS |
| Galderma Laboratories, L.P. | $40.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145313985 | CMS |
| Galderma Laboratories, L.P. | $70.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145313987 | CMS |
| Galderma Laboratories, L.P. | $34.02 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145313989 | CMS |
| MERZ NORTH AMERICA, INC. | $3.53 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146370661 | CMS |
| MERZ NORTH AMERICA, INC. | $131.89 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146370663 | CMS |
| MERZ NORTH AMERICA, INC. | $28.17 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146370665 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.91 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923400 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.64 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923402 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.